To access the full text documents, please follow this link: http://hdl.handle.net/10230/37158
dc.contributor.author | Torre Fornell, Rafael de la |
---|---|
dc.contributor.author | De Sola Llopis, Susana |
dc.contributor.author | Xicota Vila, Laura, 1987- |
dc.contributor.author | Cuenca Royo, Aida Ma, 1981- |
dc.contributor.author | Rodriguez, Joan |
dc.contributor.author | Gomis González, Maria |
dc.contributor.author | Hernández, Gimena |
dc.contributor.author | Del Hoyo Soriano, Laura |
dc.contributor.author | Ozaita Mintegui, Andrés, 1969- |
dc.contributor.author | Dierssen, Mara |
dc.contributor.author | TESXF Study Group |
dc.contributor.author | Principe, Alessandro |
dc.contributor.author | Espadaler, Josep María |
dc.contributor.author | Roca, Laia |
dc.contributor.author | Del Hoyo Soriano, Laura |
dc.contributor.author | Farré Albaladejo, Magí |
dc.contributor.author | Fitó Colomer, Montserrat |
dc.contributor.author | León Jorba, Alba |
dc.contributor.author | Banea, Ovideo |
dc.contributor.author | Maldonado, Rafael, 1961- |
dc.contributor.author | Busquets Garcia, Arnau, 1985- |
dc.date | 2019 |
dc.identifier.citation | de la Torre R, de Sola S, Farré M, Xicota L, Cuenca-Royo A, Rodriguez J et al. A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome. Clin Nutr. 2019. pii: S0261-5614(19)30082-2. DOI 10.1016/j.clnu.2019.02.028 |
dc.identifier.citation | 0261-5614 |
dc.identifier.citation | http://dx.doi.org/10.1016/j.clnu.2019.02.028 |
dc.identifier.uri | http://hdl.handle.net/10230/37158 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation | Clin Nutr. 2019. pii: S0261-5614(19)30082-2 |
dc.relation | info:eu-repo/grantAgreement/ES/1PE/SAF2013-49129-C2-1-R |
dc.relation | info:eu-repo/grantAgreement/ES/1PE/SAF2016-79956-R |
dc.rights | info:eu-repo/semantics/embargoedAccess |
dc.rights | © Elsevier http://dx.doi.org/10.1016/j.clnu.2019.02.028 |
dc.subject | Fragile-X syndrome |
dc.subject | Epigallocatechin gallate |
dc.subject | Cognition |
dc.subject | Functionality |
dc.title | A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract | |
dc.description.abstract | |
dc.description.abstract |